Kerecis requests that their press release NewsItemId: 20250603277113 issued June 3, 2025 "Blue Cross and Blue Shield of ...

Kerecis has launched SurgiClose Silicone, a product combining fish-skin graft with silicone backing to treat surgical and trauma wounds. There are two variants available for this device ...

Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration, today announced that Cigna, one of the largest health insurers in ...

SAWC is currently taking place in Las Vegas through October 5, 2024. The Kerecis booth is number 517. Kerecis will release an important announcement regarding exciting new research tomorrow ...

ARLINGTON, Va.--(BUSINESS WIRE)--Kerecis ® Shield™, the new fish-skin wound-treatment product family for private doctors’ clinics, has been approved by multiple leading Medicare ...

Product combines fish-skin grafts and silicone for soft-tissue repair Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue ...

Coloplast A/S is acquiring Kerecis hf, a closely held Icelandic maker of fish-skin dressings to treat human wounds, for an enterprise value of up to $1.3 billion. Coloplast is making a $1.2 ...

Founded in 2007, the Icelandic company Kerecis has developed fish-skin soft-tissue regeneration products that can be used to protect the body’s tissues and create an environment that facilitates ...

Kerecis, the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue regeneration, ...

The decision provides access to Kerecis’ intact fish-skin technology for more than 1.6 million BCBSLA members, marking a meaningful expansion of regenerative wound care in the Gulf South.